ProMES study (prostate biopsies using MR-Ultrasound fusion study).

The role of targeted MRI-ultrasound fusion biopsies of the prostate in patients suspected for prostate cancer.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON28981

Enrollment

350

Registered

2018-01-19

Start date

2018-02-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MRI-ultrasound fusion biopsies Prostate cancer Prostate biopsies Targeted biopsies MRI-Echo fusiebiopten Prostaatkanker Prostaatbiopten

Interventions

We will perform a observational diagnostic study in which two different methods for taking prostate biopsies within the same patient will be compared, namely standardized ultrasound guided biopsies an

Eligibility

Inclusion criteria

Inclusion criteria: - Age>18 years - Indication for undergoing prostate biopsies for the first time - Written informed consent

Exclusion criteria

Exclusion criteria: - Patients who are suspected in advance to have bone metastases - Patient not able to undergo MRI - Former prostate biopsies

Design outcomes

Primary

Measure	Time frame
All found prostate cancers.	—

Secondary

Measure	Time frame
- Classification of the found prostate cancers - The amount of patients eligible for Active Surveillance	—

Contacts

Public ContactM.G. Steffens

m.steffens@isala.nl0384244905

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)